Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Opexa Therapeutics Inc (NASDAQ:OPXA)

0.905
Delayed Data
As of Jan 20
 -0.005 / -0.55%
Today’s Change
0.50
Today|||52-Week Range
4.93
-1.63%
Year-to-Date
No recent news for Opexa Therapeutics Inc.

Today’s Trading

Previous close0.91
Today’s open0.90
Day’s range0.90 - 0.96
Volume219,376
Average volume (3 months)985,342
Market cap$6.5M
Dividend yield--
Data as of 4:00pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)+52.55%
Earnings growth (this year)+45.49%
Earnings growth (next 5 years)--
Revenue growth (last year)+100.99%
P/E ratioNM
Price/Sales6.34
Price/Book0.66

Competitors

 Today’s
change
Today’s
% change
ACURAcura Pharmaceutical...+0.03+6.18%
CBIOCatalyst Biosciences...+0.02+2.63%
SSKNSTRATA Skin Sciences...-0.05-8.77%
BSPMBiostar Pharmaceutic...-0.09-3.09%
Data as of 4:00pm ET, 01/20/2017

Financials

Next reporting dateMarch 14, 2017
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$2.6M
Annual profit (last year)-$12.0M
Net profit margin-470.18%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer, CFO &
Director
Neil K. Warma
Chief Scientific Officer
Donald Healey
Corporate headquarters
The Woodlands, Texas

Forecasts


Search for Jobs